For decades, scientists have been all about DNA when it comes to cancer. But new research from Virginia Tech and Tel Aviv ...
In a recent study, Stevens researchers have shown how colorectal cancers can evolve from mature intestinal cells that revert ...
Median PFS at 7.0 months, median DoR is 9.3 months with DCR of 79.5% in metastatic NSCLC patients with acquired ...
MAIA’s novel telomere-targeting therapy being evaluated as a third-line treatment for advanced non-small cell lung cancer CHICAGO, June 04, 2026 ...
Researchers found that smaller cancer cells with doubled DNA often behaved more aggressively than larger ones.
What makes cancer an especially insidious disease is its ability to evade your own body’s defenses. Tumors have a host of ...
Izalontamab brengitecan more than doubled PFS compared with chemotherapy ...
The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful ...
WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...